- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 16, 1998
0-27352
(Commission File Number)
------------------------------
HYBRIDON, INC.
(Exact name of registrant as specified in its charter)
Delaware 3072298
- --------------------------------------------------------------------------------
(State of Incorporation) (IRS Employer
Identification Number)
620 Memorial Drive, Cambridge, Massachusetts 02139
- --------------------------------------------------------------------------------
(Address of registrant's principal executive office)
(617) 528-7000
- --------------------------------------------------------------------------------
(Registrant's telephone number)
------------------------------
- --------------------------------------------------------------------------------
<PAGE>
ITEM 5. Other Events
On January 23, 1998, Hybridon, Inc. (the "Company") issued a press
release announcing that the Company has satisfied the 20 Unit minimum offering
threshold for the private placement, the commencement of which was previously
announced by the Company. A copy of the release has been filed with this Current
Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
Exhibit Number Title
- -------------- -----
99.1 Press Release dated January 23, 1998
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
HYBRIDON, INC.
By: /s/ E. ANDREWS GRINSTEAD, III
-----------------------------
Name: E. Andrews Grinstead, III
Title: Chairman of the Board,
President and Chief
Executive Officer
Date: February 2, 1998
FOR IMMEDIATE RELEASE
Exhibit 99.1
------------
Company Press Release
SOURCE: Hybridon, Inc.
Hybridon Announces Satisfaction of the Minimum 20 Unit
Private Placement Offering Amount
CAMBRIDGE, Mass., Jan. 23/PRNewswire/-- Hybridon, Inc. (OTC Bulletin Board: HYBN
- - news) today announced it has satisfied the 20 Unit minimum offering threshold
for the private placement announced by the Company yesterday.
Hybridon, headquartered in Cambridge, Massachusetts, is engaged in the discovery
and development of genetic medicines for the treatment of certain diseases,
based primarily on antisense technology. Antisense technology attempts to use
synthetic segments of DNA and RNA to stop the production of disease-associated
proteins by interacting at the genetic level with target strands of messenger
RNA.
SOURCE: Hybridon, Inc.